November 10, 2017 Licensing, IP, and Legal Life Science Tools

ERS Genomics and Cellecta, Inc. Sign License Agreement on CRISPR/Cas9 Genome Editing Patents for Tools and Services

DUBLIN, Ireland, and Mountain View, CA, November 10, 2017 – ERS Genomics Ltd. and Cellecta, Inc. announced today a non-exclusive license agreement to provide Cellecta with worldwide access to ERS Genomics’ CRISPR/Cas9 genome editing intellectual property for use in informing research tools and services. ERS Genomics holds rights to the foundational CRISPR/Cas9 patent portfolio from Dr. Emmanuelle Charpentier, who... Read more

November 10, 2017 Licensing, IP, and Legal

Roche’s OCREVUS (ocrelizumab) gains positive CHMP opinion for relapsing forms of multiple sclerosis and primary progressive multiple sclerosis

Basel, 10 November 2017 Roche’s OCREVUS (ocrelizumab) gains positive CHMP opinion for relapsing forms of multiple sclerosis and primary progressive multiple sclerosis If approved, OCREVUS will be an important treatment option for people with active relapsing forms of multiple sclerosis (RMS) showing superior efficacy on three major markers of disease activity and disability progression compared... Read more

November 9, 2017 Environ, Ag./Food & Bev Licensing, IP, and Legal M&A, Partnerships

Photonic BioSystems, Inc. Announces Out-Licensing Program for Microbiological Sensing and Liquid Handling Technologies

Technology originally developed for Department of Defense field applications REDMOND, Wash., Nov. 9, 2017 /PRNewswire/ — Photonic BioSystems (www.photonicbiosystems.com) announces that they are actively seeking commercialization partners (licensees) to bring their Rapid Microbial Detection and Sampling technologies to market.  The technologies enable rapid sampling, detection and measurement of bacteria, cells, microorganisms and microbial contaminants – including E. coli,... Read more

November 7, 2017 Informatics & Software Licensing, IP, and Legal

GENOHM ACHIEVES ISO 9001:2015 CERTIFICATION

Lausanne (Switzerland), 11.02.2017: Genohm, the makers of SLIMS, the LIMS+ELN platform, has successfully achieved ISO 9001:2015 certification. ISO 9001 is an internationally recognized standard that specifies the requirements for a Quality Management System (QMS) in a company. QMS impacts a company at every level, from daily administrative operations, to product development, marketing and sales, and... Read more

October 27, 2017 Clinical Research/Diagn. Licensing, IP, and Legal Product Launch

New OCREVUS (ocrelizumab) data at ECTRIMS advance clinical understanding of underlying progression in multiple sclerosis

Basel, 27 October 2017 New OCREVUS (ocrelizumab) data at ECTRIMS advance clinical understanding of underlying progression in multiple sclerosis Data show superiority of OCREVUS compared to Rebif (interferon beta-1a) in significantly reducing disability Progression Independent of Relapse Activity (PIRA) in people with relapsing multiple sclerosis (RMS) Data demonstrates first method to automatically detect and characterise... Read more